13F filing recap · Q4 2025
What did Kahn Brothers Group buy in Q4 2025?
Reported stock-position changes between this filing and the previous one.
Stock value
$564.70M
Positions
54
Estimated turnover
3.9%
Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.
Quarter in review
Kahn Brothers Group opened a new position in Tphgreenwich Trust Uni and trimmed a broad set of holdings, including Citigroup, Bayer, Flagstar Bank, Merck, Walt Disney, BP, Seaboard, and Pfizer. It also reduced Bristol-Myers Squibb, GSK, and IBM, while adding to Exxon Mobil, Tourmaline Oil, Microsoft, JPMorgan Chase, and PNC Financial Services. Notable increases included Blackstone and Brookfield Corporation, and substantial cuts were made to American Express, Antero Resources, and Rafael Holdings.